| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,751,092 ) |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA288372 | Targeting Disease Specific Tn Antigen in Pancreatic Cancer | 001 | 3 | NIH | 12/11/2025 | $516,250 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES033531 | Vascular Toxicity of Benzene | 000 | 3 | NIH | 12/18/2025 | $664,616 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES027778 | Mechanism for arsenic induced carcinogenesis | 000 | 8 | NIH | 12/18/2025 | $662,892 |
| | 2026 | 2026 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | T9952107 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $1,175,000 |
| | 2026 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | U1Q53059 | Geriatrics Workforce Enhancement Program | 02 | 2 | HRSA | 11/25/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | M0154897 | Behavioral Health Workforce Education and Training Program | 01 | 1 | HRSA | 12/22/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | D8746115 | Dental Faculty Loan Repayment | 01 | 4 | HRSA | 12/18/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03DE033729 | lluminating the Role of the Novel G Protein-Coupled P2Y10 Receptor in Sjögren’s Disease Pathophysiology | 000 | 2 | NIH | 12/1/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA280141 | Lectikines for Immunotherapy against Ovarian Cancer | 000 | 2 | NIH | 12/1/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HG011598 | Utility of Genomic Sequencing in Community Care Contexts | 000 | 4 | NIH | 12/5/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY035885 | The role of plasticity in loss of vision caused by retinitis pigmentosa | 000 | 1 | NIH | 11/25/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K01ES033289 | Evaluating mechanisms of sex differences in environmentally-induced metabolic diseases | 000 | 3 | NIH | 12/5/2025 | -$12,390 |
| | 2026 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H79TI082725 | Integrated Care for Persons with Co-Occurring Disorders | 000 | 5 | SAMHSA | 11/14/2025 | -$164,644 |
| | 2026 | 2024 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R37CA234002 | Targeting 6-Phosphofructo-2-Kinase to increase efficacy of CDK4/6 Inhibitors | 000 | 5 | NIH | 11/25/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI139671 | Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis | 000 | 5 | NIH | 12/17/2025 | -$7,873 |
| | 2026 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R34MH124799 | A Pilot Randomized Control Trial of a Relapse Prevention Online Exposure Protocol for Eating Disorders and Mechanisms of Change | 000 | 3 | NIH | 11/17/2025 | -$1,809 |
| | 2026 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA263107 | Mechanisms underlying radiation-induced dysphagia | 000 | 2 | NIH | 12/9/2025 | -$3,888 |
| | 2026 | 2023 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21ES033334 | Benzene Exposure and Heart Failure | 000 | 2 | NIH | 11/21/2025 | -$2,335 |
| | 2026 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21AG070659 | Global significance test based on quantile regression with applications to genomic studies of Alzheimer’s disease | 000 | 2 | NIH | 12/1/2025 | $0 |
| | 2026 | 2022 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL147856 | Mechanisms underlying metal nanoparticle-induced lung injury and fibrosis | 000 | 4 | NIH | 12/4/2025 | $0 |
| | 2026 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS097781 | Altered Motor Function & Force Feedback After Spinal Cord Injury | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL139047 | Remote Hind Limb Ischemia Mechanism of Cardioprotection | 000 | 4 | NIH | 12/30/2025 | -$22,834 |
| | 2026 | 2021 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL139047 | Remote Hind Limb Ischemia Mechanism of Cardioprotection | 000 | 4 | NIH | 12/30/2025 | -$51,893 |
|
| Issue Date FY: 2025 ( Subtotal = $87,640,574 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168198 | Role of the PEP cycle in cardiac fibrosis | 001 | 2 | NIH | 8/19/2025 | $58,196 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21EY034674 | Detailed Molecular Structures of Tear Film Lipid Layer for Improved Treatment of Dry Eye Syndrome | 000 | 2 | NIH | 11/21/2024 | $183,077 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA276284 | Mechanism of double-negative T cells in antitumor immunity to breast cancer | 002 | 4 | NIH | 9/5/2025 | $352,757 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA305985 | Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease | 000 | 1 | NIH | 6/12/2025 | $649,021 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 001 | 3 | NIH | 5/22/2025 | $35,304 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 000 | 3 | NIH | 3/20/2025 | $317,740 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL158779 | Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19 | 000 | 4 | NIH | 9/8/2025 | $720,048 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL150581 | Epidural spinal cord stimulation and respiratory motor function after injury | 001 | 5 | NIH | 6/26/2025 | $74,615 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL150581 | Epidural spinal cord stimulation and respiratory motor function after injury | 000 | 5 | NIH | 4/18/2025 | $671,527 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK131442 | The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation | 000 | 3 | NIH | 4/16/2025 | $398,430 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS131489 | Converting the glial scar to neurons repairs the injured neural circuits for functional recovery following spinal cord injury | 001 | 2 | NIH | 8/13/2025 | $348,693 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA030485 | Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention | 000 | 4 | NIH | 8/18/2025 | $659,430 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA029798 | Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease | 001 | 5 | NIH | 8/14/2025 | $104,281 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA029798 | Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease | 000 | 5 | NIH | 7/31/2025 | $353,403 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H7600536 | EARLY INTERVENTION SERVICES | 00 | 26 | HRSA | 4/28/2025 | $188,298 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H7600536 | EARLY INTERVENTION SERVICES | 02 | 26 | HRSA | 8/21/2025 | $376,604 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H7600536 | EARLY INTERVENTION SERVICES | 01 | 26 | HRSA | 8/4/2025 | $188,298 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | UG3NS140971 | Gastric Electrical Stimulation for Pain in Gastroparesis | 000 | 1 | NIH | 6/9/2025 | $451,297 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K99ES036286 | Unraveling the molecular link between heavy metal exposure and triple-negative breast cancer | 000 | 2 | NIH | 8/22/2025 | $124,087 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA028905 | Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease | 000 | 4 | NIH | 5/12/2025 | $408,636 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K23AA029198 | Lactobacillus rhamnosus: A Novel Probiotic Therapy for treating Alcohol Use Disorder | 000 | 5 | NIH | 7/9/2025 | $140,775 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS138333 | Cell type-specific effects of the integrated stress response pathway after traumatic spinal cord injury | 000 | 1 | NIH | 5/7/2025 | $591,304 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21ES038074 | Environmental and Health Assessment Following the Westlake Vinyl Fire: A Time-Sensitive Study | 000 | 1 | NIH | 9/11/2025 | $431,750 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES036210 | RNA modifications in apolipoprotein regulation by environmental exposures | 000 | 1 | NIH | 9/10/2025 | $3,051,769 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 004 | 4 | NIH | 9/11/2025 | $79,055 |
|
